Skip to content

Fluid therapy in pregnancy in cesarian section

Comparison of fluid therapy based on plethysmographic Variability Index (PVI) and conventional method in spontaneous breathing patients on postoperative lactate levels in patients undergoing cesarian section surgery under spinal anesthesia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2016010525856N1
Enrollment
70
Registered
2017-01-14
Start date
2016-07-22
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Abnormal blood-pressure reading, without diagnosis. Abnormal blood-pressure reading, without diagnosis

Interventions

Intervention 1: 5 cc/kg crystalloid fluid is infused as the bolus, spinal anesthesia is induced and then 2cc/kg/hour of fluid is maintained, once PVI > 13 %, a 250 mL crystalloid is rapidly infused an
Treatment - Other
5 cc/kg crystalloid fluid is infused as the bolus, spinal anesthesia is induced and then 2cc/kg/hour of fluid is maintained, once PVI > 13 %, a 250 mL crystalloid is rapidly infused and repeated for e
5 cc/kg crystalloid fluid is infused as the bolus, spinal anesthesia is induced and then 4-8 mL/kg/h crystalloid fluid infusion is maintained

Sponsors

Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Patients aged 18 to 50 years; American Society of anesthesiologists physical status class I and II; A body mass index (BMI) less than 30 kilograms per cubic meter. Exclusion criteria: History of systemic (cardiovascular, renal, hepatic, or vascular) disorders; Need to planned pharmacologic or mechanical cardiovascular manipulation; Needing repeated blood sampling; Failure of indirect arterial blood pressure measurement; Supplementary diagnostic information from the arterial waveform; Needing central venous pressure monitoring; Needing pulmonary artery catheterization and monitoring; Requiring transvenous cardiac pacing; Needing temporary hemodialysis; Need to aspirate air emboli; Inadequate peripheral intravenous access; Prolonged surgery (longer than 3 hours);

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Total amount of intraoperative fluids infused after fluid therapy according to plethysmographic variability index (PVI). Timepoint: End of surgery. Method of measurement: Milliliter.;Amounts of lactate in fluid therapy according to PVI (plethysmographic variation Index). Timepoint: On admission as well as at the end of surgery. Method of measurement: Millimole/liter , Enzymatic.;Mean arterial pressure during fluid therapy according to PVI (plethysmographic variation index). Timepoint: before anesthesia as well as 1, 2, 3, and 5 minutes after that. Method of measurement: Using patients monitoring - millimeter of mercury.;Total amounts of Urine output after fluid therapy according to PVI (plethysmographic variation index). Timepoint: End of surgery. Method of measurement: Milliliter.

Secondary

MeasureTime frame
Total amount of intraoperative fluids infused after fluid therapy according to conventional method. Timepoint: End of surgery. Method of measurement: Milliliter.;Amounts of lactate in fluid therapy according to conventional method. Timepoint: on admission as well as at the end of surgery. Method of measurement: Millimole/liter, Enzymatic.;Mean arterial pressure during fluid therapy according to conventional method. Timepoint: Before anesthesia as well as 1, 2, 3, and 5 minutes after that. Method of measurement: Using patients monitoring - millimeter of mercury.;Total amounts of Urine output after fluid therapy according to conventional method. Timepoint: End of surgery. Method of measurement: Milliliter.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Siamak Tavakoli

Dr. Shariati Hospital

S_tavakoli@razi.tums.ac.ir+98 21 8822 0033

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026